Enobia Pharma
About:
Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
Website: http://www.enobia.com
Twitter/X: Enobia
Top Investors: OrbiMed, Fonds de solidarité FTQ, Desjardins Venture Capital, CTI Life Sciences Fund, CTI Capital
Description:
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.
Total Funding Amount:
$158M
Headquarters Location:
Montreal, Quebec, Canada
Founded Date:
1997-01-01
Contact Email:
help(AT)laldeficiencyregistry.com
Founders:
Number of Employees:
1001-5000
Last Funding Date:
2011-08-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai